DUBLIN (AP) — DUBLIN (AP) — Jazz Pharmaceuticals PLC (JAZZ) on Tuesday reported fourth-quarter earnings of $203.5 million.
The Dublin-based company said it had profit of $3.21 per share. Earnings, adjusted for one-time gains and costs, came to $6.64 per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $6.62 per share.
The drugmaker posted revenue of $1.2 billion in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $1.18 billion.
For the year, the company reported a loss of $356.1 million, or $5.84 per share. Revenue was reported as $4.27 billion.
Jazz expects full-year revenue in the range of $4.25 billion to $4.5 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on JAZZ at https://www.zacks.com/ap/JAZZ
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
